Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
40
DHC Quote, Financials, Valuation and Earnings
Last price:
$3.59
Seasonality move
:
-3.45%
Day range:
$3.57 - $3.76
52-week range:
$2.00 - $4.24
Dividend yield:
1.08%
P/E ratio:
--
P/S ratio:
0.59x
P/B ratio:
0.46x
Volume:
941.2K
Avg. volume:
1M
1-year change:
7.14%
Market cap:
$895M
Revenue:
$1.5B
EPS (TTM):
-$1.23
Analysts' Opinion
-
Consensus RatingDiversified Healthcare Trust has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 1 Buy rating, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $3.75, Diversified Healthcare Trust has an estimated upside of 1.08% from its current price of $3.60.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $3.00 representing 100% downside risk from its current price of $3.60.
Fair Value
-
According to the consensus of 2 analysts, Diversified Healthcare Trust has 1.08% upside to fair value with a price target of $3.75 per share.
DHC vs. S&P 500
-
Over the past 5 trading days, Diversified Healthcare Trust has overperformed the S&P 500 by 1.3% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Diversified Healthcare Trust does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Diversified Healthcare Trust has grown year-over-year revenues for 10 quarters straight. In the most recent quarter Diversified Healthcare Trust reported revenues of $386.9M.
Earnings Growth
-
Diversified Healthcare Trust earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Diversified Healthcare Trust reported earnings per share of -$0.04.
Enterprise value:
3.4B
EV / Invested capital:
--
Price / LTM sales:
0.59x
EV / EBIT:
--
EV / Revenue:
2.24x
PEG ratio (5yr expected):
-0.07x
EV / Free cash flow:
42.21x
Price / Operating cash flow:
11.07x
Enterprise value / EBITDA:
15.09x
Gross Profit (TTM):
$268.3M
Return On Assets:
-5.61%
Net Income Margin (TTM):
-19.38%
Return On Equity:
-14.15%
Return On Invested Capital:
-5.98%
Operating Margin:
-1.24%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $1.3B | $1.4B | $1.5B | $370.8M | $386.9M | |
| Gross Profit | $192.5M | $239.4M | $268.3M | $63.2M | $72.5M | |
| Operating Income | -$79.4M | -$77.9M | -$42.8M | -$14.5M | -$4.8M | |
| EBITDA | $135.3M | $182.5M | $224.9M | $39.8M | $115.8M | |
| Diluted EPS | -$1.29 | -$1.37 | -$1.23 | -$0.36 | -$0.04 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.2B | $1.5B | $382.7M | $246.3M | $386.4M | |
| Total Assets | $7.5B | $6.8B | $5.7B | $5.3B | $5B | |
| Current Liabilities | $853.2M | $745.6M | $482M | $24M | $26.9M | |
| Total Liabilities | $5B | $3.9B | $3.1B | $3.1B | $3B | |
| Total Equity | $2.5B | $2.9B | $2.6B | $2.2B | $1.9B | |
| Total Debt | $3.9B | $3.5B | $2.8B | $2.8B | $2.8B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$27M | $33M | $80.4M | $28.6M | -$3.2M | |
| Cash From Investing | -$257.4M | -$204.2M | $162.9M | -$58.8M | $291.1M | |
| Cash From Financing | -$824.9M | -$3.3M | -$144.8M | -$8.6M | -$131M | |
| Free Cash Flow | -$27M | $33M | $80.4M | $28.6M | -$3.2M | |
DHC
Sector
Market Cap
$895M
$1B
Price % of 52-Week High
87.5%
84.86%
Dividend Yield
1.08%
3.17%
Shareholder Yield
2.38%
4.03%
1-Year Price Total Return
8.16%
--
Beta (5-Year)
2.452
0.765
Dividend yield:
1.08%
Annualized payout:
$0.04
Payout ratio:
-3.29%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$3.72
200-day SMA
Buy
Level
$2.85
Bollinger Bands (100)
Buy
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$3.67
Relative Strength Index (RSI14)
Buy
Level
51.04
ADX Line
Neutral
Level
0
Williams %R
Neutral
Level
-46.9136
50-day SMA
Buy
Level
$3.39
MACD (12, 26)
Buy
Level
1.03
25-day Aroon Oscillator
Buy
Level
88
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.326)
Sell
CA Score
(Annual)
Level (-0.9027)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (0.718)
Buy
Piotroski F Score
(Annual)
Level (6)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs. Majority of revenue is from SHOP segment.
Stock Forecast FAQ
In the current month, DHC has received 1 Buy ratings 1 Hold ratings, and 0 Sell ratings. The DHC average analyst price target in the past 3 months is $3.75.
-
Where Will Diversified Healthcare Trust Stock Be In 1 Year?
According to analysts, the consensus estimate is that Diversified Healthcare Trust share price will rise to $3.75 per share over the next 12 months.
-
What Do Analysts Say About Diversified Healthcare Trust?
Analysts are divided on their view about Diversified Healthcare Trust share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Diversified Healthcare Trust is a Sell and believe this share price will drop from its current level to $3.00.
-
What Is Diversified Healthcare Trust's Price Target?
The price target for Diversified Healthcare Trust over the next 1-year time period is forecast to be $3.75 according to 2 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is DHC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Diversified Healthcare Trust is a Leans Bullish. 1 of 2 analysts rates the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of DHC?
You can purchase shares of Diversified Healthcare Trust via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Diversified Healthcare Trust shares.
-
What Is The Diversified Healthcare Trust Share Price Today?
Diversified Healthcare Trust was last trading at $3.59 per share. This represents the most recent stock quote for Diversified Healthcare Trust. Yesterday, Diversified Healthcare Trust closed at $3.60 per share.
-
How To Buy Diversified Healthcare Trust Stock Online?
In order to purchase Diversified Healthcare Trust stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
93
EXOD alert for Jul 18
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
